title: Q: Who should receive the shingles vaccine?
authors.affiliation: Division of Hospital Medicine, University of California San Francisco, USA.
authors.forename: Aparajita
authors.initials: A
authors.lastname: Singh
authors.forename: Kristin
authors.initials: K
authors.lastname: Englund
mesh_terms: D000368:Aged; D003362:Cost-Benefit Analysis; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000009:adverse effects / Q000191:economics / Q000276:immunology*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D014481:United States; D014611:Vaccination
chemical_list: D053061:Herpes Zoster Vaccine